While much attention has been devoted to TEX as potential cancer biomarkers and their contribution to cancer progression, immune cell-derived sEV are now emerging as equally important contributors to the unique tumor-orchestrated immune landscape in cancer. The gene discussed is TEX46; the disease is cancer.